| |
| |
|
| Insider
Information: |
Kamdar Kim P. |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
17 |
|
| Direct
Shares |
170,828 |
|
|
Indirect Shares
|
3,947,811 |
|
|
| Direct
Value |
$6,867,447 |
|
|
|
Indirect Value
|
$494,250 |
|
|
| Total
Shares |
4,118,639 |
|
|
| Total
Value |
$7,361,697 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clovis Oncology, Inc. |
CLVS |
10% Owner |
|
0 |
2011-11-15 |
32,758 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
|
0 |
2011-01-01 |
1,963 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2011-01-01 |
25,000 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
|
0 |
2011-01-01 |
11,000 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
2014-11-17 |
0 |
2012-07-18 |
6,250 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-06-25 |
21,471 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2017-12-11 |
0 |
2013-07-15 |
47,963 |
Premium* |
|
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
2016-11-01 |
0 |
2013-08-21 |
17,171 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-24 |
5,250 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2014-05-01 |
10,358 |
|
0 |
Premium* |
|
|
Marinus Pharmaceuticals Inc |
MRNS |
10% Owner |
2014-07-31 |
42,550 |
|
0 |
Premium* |
|
|
Evofem Biosciences Inc |
EVFM |
Director |
2023-12-21 |
0 |
2019-05-21 |
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
10% Owner |
2015-05-06 |
12,572 |
|
0 |
Premium* |
|
|
Glaukos Corp |
GKOS |
10% Owner |
2015-06-24 |
63,200 |
|
0 |
Premium* |
|
|
ReShape Lifesciences Inc |
RSLS |
Director |
2019-08-06 |
27,148 |
2016-10-12 |
0 |
Premium* |
|
|
Singular Genomics Systems, Inc. |
OMIC |
Director |
2023-08-15 |
15,000 |
2023-08-15 |
3,778,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
35 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2011-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,000 |
|
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
– – • |
2014-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,358 |
|
- |
|
| LIFE |
aTyr Pharma Inc |
10% Owner |
– – • |
2015-05-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,572 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2011-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,500 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2014-03-19 |
4 |
D |
$14.00 |
$385,000 |
I/I |
(27,500) |
0 |
0 |
- |
|
| CLVS |
Clovis Oncology, Inc. |
10% Owner |
– – • |
2011-11-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
32,758 |
|
- |
|
| DRTX |
Durata Therapeutics, Inc. |
10% Owner |
– – • |
2012-07-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,250 |
|
- |
|
| DRTX |
Durata Therapeutics, Inc. |
10% Owner |
– – • |
2014-11-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,250) |
0 |
0 |
- |
|
| ESPR |
Esperion Therapeutics, In... |
10% Owner |
– – • |
2013-06-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
21,471 |
|
- |
|
| EVFM |
Evofem Biosciences Inc |
Director |
– • • |
2014-11-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,934 |
|
- |
|
| EVFM |
Evofem Biosciences Inc |
Director |
– • – |
2019-05-21 |
4 |
S |
$5.07 |
$3,321 |
I/I |
(655) |
0 |
0 |
- |
|
| EVFM |
Evofem Biosciences Inc |
Director |
– • – |
2019-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,287 |
4,287 |
0 |
- |
|
| EVFM |
Evofem Biosciences Inc |
Director |
– • • |
2020-06-12 |
4 |
B |
$2.94 |
$14,700 |
D/D |
5,000 |
9,287 |
3.92 |
- |
|
| EVFM |
Evofem Biosciences Inc |
Director |
– • – |
2021-06-18 |
4 |
B |
$1.17 |
$11,650 |
D/D |
10,000 |
19,287 |
2.39 |
- |
|
| EVFM |
Evofem Biosciences Inc |
Director |
– • – |
2023-12-21 |
4 |
S |
$0.62 |
$6 |
D/D |
(10) |
0 |
0 |
- |
|
| EVOK |
Evoke Pharma Inc |
10% Owner |
– – • |
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,250 |
|
- |
|
| GKOS |
Glaukos Corp |
10% Owner |
– – • |
2015-06-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
63,200 |
|
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
10% Owner |
– – • |
2014-07-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,550 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
47,963 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2017-12-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(47,963) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2011-01-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,963 |
|
- |
|
| RSLS |
ReShape Lifesciences Inc |
Director |
– • – |
2016-10-12 |
4 |
B |
$15.00 |
$201,000 |
D/D |
13,400 |
13,400 |
2.39 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Director |
– • – |
2018-08-23 |
4 |
B |
$1.82 |
$100,000 |
D/D |
54,945 |
68,345 |
2.39 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Director |
– • – |
2019-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
78,125 |
146,470 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Director |
– • – |
2019-08-06 |
4 |
B |
$4.00 |
$50,000 |
D/D |
12,500 |
27,148 |
2.39 |
- |
|
35 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
